Are Analysts Expecting A Better 2020 For Astrazeneca plc ADR (AZN)?
Astrazeneca plc ADR (AZN) concluded trading on Wednesday at a closing price of $72.22, with 4.17 million shares of worth about $301.51 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -7.30% during that period and on April 03, 2025 the price saw a […]
Astrazeneca plc ADR (AZN) Volatility Spurs A Quest For Clarity
Currently, there are 3.10B common shares owned by the public and among those 3.10B shares have been available to trade. The company’s stock has a 5-day price change of -5.22% and 13.36% over the past three months. AZN shares are trading 11.49% year to date (YTD), with the 12-month market performance up to 10.36% higher. […]
Astrazeneca plc ADR (NASDAQ: AZN) Stock In Prove Me State
Astrazeneca plc ADR (AZN) concluded trading on Wednesday at a closing price of $76.32, with 4.05 million shares of worth about $309.12 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -3.44% during that period and on Wednesday the price saw a loss of […]
Why Should You Put Astrazeneca plc ADR (NASDAQ: AZN) On Your Portfolio?
Currently, there are 3.10B common shares owned by the public and among those 3.10B shares have been available to trade. The company’s stock has a 5-day price change of 0.80% and 19.30% over the past three months. AZN shares are trading 15.08% year to date (YTD), with the 12-month market performance up to 17.57% higher. […]
Are Analysts Expecting A Better 2020 For Astrazeneca plc ADR (AZN)?
Astrazeneca plc ADR (AZN) concluded trading on Wednesday at a closing price of $73.81, with 3.96 million shares of worth about $292.33 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -12.56% during that period and on February 19, 2025 the price saw a […]
Gains May Be On The Menu For Astrazeneca plc ADR (NASDAQ: AZN)
Currently, there are 3.10B common shares owned by the public and among those 3.10B shares have been available to trade. The company’s stock has a 5-day price change of 5.47% and 12.43% over the past three months. AZN shares are trading 11.00% year to date (YTD), with the 12-month market performance up to 14.50% higher. […]
Look At Analyst Expectations For A Better Read On Astrazeneca plc ADR (NASDAQ: AZN)
Currently, there are 3.10B common shares owned by the public and among those 3.10B shares have been available to trade. The company’s stock has a 5-day price change of 4.01% and 13.80% over the past three months. AZN shares are trading 10.90% year to date (YTD), with the 12-month market performance up to 9.18% higher. […]
Astrazeneca plc ADR (NASDAQ: AZN): Hunting Genuine Value In Market Debris
Currently, there are 3.10B common shares owned by the public and among those 3.10B shares have been available to trade. The company’s stock has a 5-day price change of 5.91% and 1.94% over the past three months. AZN shares are trading -3.43% year to date (YTD), with the 12-month market performance down to -4.28% lower. […]
Analyst Expect Big Moves From Astrazeneca plc ADR (NASDAQ: AZN)
Currently, there are 3.10B common shares owned by the public and among those 3.10B shares have been available to trade. However, the script later moved the day high at 63.37, down -1.98%. The company’s stock has a 5-day price change of -5.15% and -2.00% over the past three months. AZN shares are trading -7.56% year […]
Handle With Care: Astrazeneca plc ADR (NASDAQ: AZN)
Currently, there are 3.10B common shares owned by the public and among those 3.10B shares have been available to trade. However, the script later moved the day high at 65.64, down -0.76%. The company’s stock has a 5-day price change of -3.05% and 1.50% over the past three months. AZN shares are trading -3.28% year […]
